Cargando…
Influence on [(18)F]FDG uptake by cancer cells after anti-PD-1 therapy in an enforced-immune activated mouse tumor
BACKGROUND: Anti-programmed cell death 1 (PD-1) antibody is an immune checkpoint inhibitor, and anti-PD-1 therapy improves the anti-tumor functions of T cells and affects tumor microenvironment. We previously reported that anti-PD-1 treatment affected tumor glycolysis by using 2-deoxy-2-[(18)F]fluor...
Autores principales: | Tomita, Mayu, Suzuki, Motofumi, Kono, Yusuke, Nakajima, Kohei, Matsuda, Takuma, Kuge, Yuji, Ogawa, Mikako |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080890/ https://www.ncbi.nlm.nih.gov/pubmed/32189078 http://dx.doi.org/10.1186/s13550-020-0608-4 |
Ejemplares similares
-
Anti PD-1 treatment increases [(18)F]FDG uptake by cancer cells in a mouse B16F10 melanoma model
por: Tomita, Mayu, et al.
Publicado: (2018) -
In Vitro and In Vivo Cell Uptake of a Cell-Penetrating Peptide Conjugated with Fluorescent Dyes Having Different Chemical Properties
por: Takakura, Hideo, et al.
Publicado: (2021) -
Correction: Takakura et al. In Vitro and In Vivo Cell Uptake of a Cell-Penetrating Peptide Conjugated with Fluorescent Dyes Having Different Chemical Properties. Cancers 2021, 13, 2245
por: Takakura, Hideo, et al.
Publicado: (2022) -
Relationship between PD-L1 expression and (18)F-FDG uptake in gastric cancer
por: Chen, Ruohua, et al.
Publicado: (2019) -
Lesion-based analysis of (18)F-FDG uptake and (111)In-Pentetreotide uptake by neuroendocrine tumors
por: Kubota, Kazuo, et al.
Publicado: (2014)